Key facts
- This page summarizes Thomas John T.'s Form 4 filing for Physicians Realty Trust.
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2022, 15:46.
Thomas John T. - 01 Mar 2022 Form 4 Insider Report for Physicians Realty Trust
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 01 Mar 2022
- Net transaction value
- -$356,604
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2022, 15:46:35 UTC
- Prior SEC filing
- 23 Feb 2022
- Next SEC filing
- 11 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher M. Bartoli, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Thomas John T. filed Form 4 for Physicians Realty Trust on 03 Mar 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: -$356,604.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DOC
transaction
Common shares, $0.01 par value
Award
- Transaction value
- $0
- Shares
- +54,429
- Change %
- +11%
- Price
- $0.000000
- Shares after
- 539,420
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
DOC
transaction
Common shares, $0.01 par value
Tax liability
- Transaction value
- $356,604
- Shares
- -21,784
- Change %
- -4.1%
- Price
- $16.37
- Shares after
- 514,788
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F2
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 217
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 434
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 217
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
DOC
holding
Common shares, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 217
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Reporting Person's child
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DOC
transaction
Derivative
2022 Performance Based Restricted Share Unit Grant
Award
- Transaction value
- $0
- Shares
- +81,644
- Change %
- Price
- $0.000000
- Shares after
- 81,644
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 81,644
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2023, subject to the terms of the grant.
Footnote F2
The reporting person transferred 2,848 shares to his former spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his former spouse.
Footnote F3
March 1, 2022 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2024.